1. Distinct contributions of partial and full EMT to breast cancer malignancy
- Author
-
Gerhard Christofori, Fabiana Lüönd, Natascha Santacroce, Carolina Hager, Fengyuan Tang, Nami Sugiyama, Stefanie Tiede, Thomas R. Bürglin, Robert Ivanek, Christian Beisel, Ruben Bill, Jacco van Rheenen, and Laura Bornes
- Subjects
Epithelial-Mesenchymal Transition ,Lung Neoplasms ,Cell ,Antineoplastic Agents ,Apoptosis ,Breast Neoplasms ,Mice, SCID ,Biology ,Malignancy ,General Biochemistry, Genetics and Molecular Biology ,Metastasis ,Mice ,Breast cancer ,Cell Movement ,Mice, Inbred NOD ,Live cell imaging ,Biomarkers, Tumor ,Tumor Cells, Cultured ,medicine ,Animals ,Humans ,Neoplasm Invasiveness ,Molecular Biology ,Cell Proliferation ,Sequence Analysis, RNA ,Mesenchymal stem cell ,Cell Biology ,medicine.disease ,Xenograft Model Antitumor Assays ,Metastatic breast cancer ,Gene Expression Regulation, Neoplastic ,medicine.anatomical_structure ,Drug Resistance, Neoplasm ,embryonic structures ,Cancer cell ,Cancer research ,Female ,Developmental Biology - Abstract
Epithelial-mesenchymal transition (EMT) is a transient, reversible process of cell de-differentiation where cancer cells transit between various stages of an EMT continuum, including epithelial, partial EMT, and mesenchymal cell states. We have employed Tamoxifen-inducible dual recombinase lineage tracing systems combined with live imaging and 5-cell RNA sequencing to track cancer cells undergoing partial or full EMT in the MMTV-PyMT mouse model of metastatic breast cancer. In primary tumors, cancer cells infrequently undergo EMT and mostly transition between epithelial and partial EMT states but rarely reach full EMT. Cells undergoing partial EMT contribute to lung metastasis and chemoresistance, whereas full EMT cells mostly retain a mesenchymal phenotype and fail to colonize the lungs. However, full EMT cancer cells are enriched in recurrent tumors upon chemotherapy. Hence, cancer cells in various stages of the EMT continuum differentially contribute to hallmarks of breast cancer malignancy, such as tumor invasion, metastasis, and chemoresistance., Developmental Cell, 56 (23), ISSN:1534-5807, ISSN:1878-1551
- Published
- 2021